On June 23, 2021 the Board of Directors of Boston Scientific Corporation upon the recommendation of the Nominating and Governance Committee, increased the number of directors comprising the Board from nine to ten and appointed David S. Wichmann to be a director of the Company, filling the vacancy created by such an increase, to hold office until the next annual meeting of stockholders, in each case, effective June 23, 2021. The Board expects to appoint Mr. Wichmann to one or more committees of the Board at a later date.